A cerebral embolism is a type of stroke that happens when a blood clot or other debris forms somewhere else in the body, travels through the bloodstream, and lodges in an artery supplying the brain. Once stuck, it blocks blood flow to brain tissue, causing damage within minutes. This makes it one of the two main mechanisms behind ischemic stroke, the other being a clot that forms directly inside a brain artery (thrombosis). Embolic strokes account for a large share of all ischemic strokes, and strokes from an unidentified embolic source alone represent roughly 18% of cases.
How a Cerebral Embolism Differs From a Thrombosis
The key distinction is where the clot originates. In a thrombotic stroke, the clot builds up at the site of blockage, usually on a damaged or narrowed artery wall inside the brain itself. In a cerebral embolism, the clot forms elsewhere and then breaks free, riding the bloodstream until it reaches a brain artery too narrow to pass through. The concept was first described in 1854 by the physician Rudolf Virchow, who found clots blocking brain arteries that clearly originated from the heart.
This difference matters for both diagnosis and treatment. On CT scans, embolic strokes tend to produce a large, uniform area of damage extending from deep brain tissue all the way to the outer cortex. Thrombotic strokes more often create patchy, uneven damage that stays deeper in the brain. Embolic strokes also have a higher rate of hemorrhagic transformation, meaning the blocked area is more likely to bleed after the initial event. Doctors can sometimes spot the clot itself on a CT scan as a bright, dense spot inside the blocked artery.
Where the Clots Come From
Most emboli are blood clots, though the source varies widely. The majority form in one of three places: the heart, a large artery leading to the brain, or (less commonly) the veins.
The Heart
Atrial fibrillation, the most common heart rhythm disorder, is the single biggest cardiac source. When the heart’s upper chambers quiver instead of contracting fully, blood pools and clots can form. These clots then get pumped out and travel to the brain. In one study of high-risk atrial fibrillation patients, 21% experienced a cerebral embolic event over three years, even while on blood thinners. Clots can also form on damaged or artificial heart valves or inside heart chambers weakened by a heart attack.
The Arteries
The carotid arteries in the neck are probably the most common arterial source. Fatty plaque builds on artery walls over years, and when a plaque ruptures, a clot forms on its surface. Pieces of that clot can break off and travel into the brain. The aorta and the vertebral arteries (which run up the back of the neck) can also shed clots in the same way.
Paradoxical Embolism
In rarer cases, a clot forms in a vein, typically in the legs, and reaches the brain by passing through a small hole in the heart wall called a patent foramen ovale (PFO). About one in four people have this opening without knowing it. When a venous clot slips through the hole into the arterial side, it bypasses the lungs and can end up in a brain artery. This is called a paradoxical embolism.
Non-Clot Emboli
Not all emboli are blood clots. Fat can enter the bloodstream after a bone fracture, air bubbles can be introduced during surgery or trauma, and clumps of bacteria can break off infected heart valves. Fat embolism affecting the brain is uncommon but can cause severe neurological symptoms. In the largest reported series of cerebral fat embolism, overall mortality was 7.4%, and about 72% of patients had a good outcome.
Symptoms of an Embolic Stroke
Because an embolus blocks blood flow suddenly rather than building up over time, symptoms typically appear all at once and at maximum severity. The specific symptoms depend on which brain artery is blocked, but common ones include sudden weakness or numbness on one side of the body, difficulty speaking or understanding speech, vision loss in one or both eyes, severe headache with no known cause, and loss of coordination or balance. Unlike a thrombotic stroke, which can sometimes develop over hours, an embolic stroke hits like a switch being flipped.
How It’s Diagnosed
The immediate priority is brain imaging, usually a CT scan, to confirm whether the stroke is caused by a blockage or a bleed. This determines what treatments are safe. Once an ischemic stroke is confirmed, doctors work to identify whether the cause is embolic. The pattern of damage on imaging helps: large areas of uniform low density reaching the cortex suggest embolism, while patchy deeper lesions suggest thrombosis.
Finding the source of the embolus is the second step and often the harder one. This typically involves heart rhythm monitoring to check for atrial fibrillation, an echocardiogram to look at the heart’s chambers and valves, and ultrasound of the carotid arteries. Despite thorough workups, the embolic source remains unidentified in a significant number of cases, a category called embolic stroke of undetermined source (ESUS).
Treatment in the First Hours
Speed defines outcomes in embolic stroke. The primary acute treatment is a clot-dissolving medication given through an IV, which works best within the first few hours after symptoms start. Not everyone qualifies: people with recent brain surgery, active bleeding, a prior stroke within the past three months, or uncontrolled high blood pressure (above 180/110) may not be able to receive it safely.
For large clots blocking major brain arteries, a procedure called mechanical thrombectomy can physically remove the clot using a catheter threaded up from the groin. Landmark trials published in 2018 showed that some patients benefit from this procedure up to 24 hours after symptoms began, provided brain imaging shows there’s still salvageable tissue. This dramatically expanded the treatment window from the previous limit of roughly 6 hours and is now part of major stroke guidelines.
Long-Term Prevention
Once someone has had a cerebral embolism, preventing a second one depends entirely on what caused the first. If atrial fibrillation is the culprit, long-term blood thinners become essential. The current standard is a class of drugs called direct-acting oral anticoagulants (DOACs), which have largely replaced older options like warfarin for most patients. In large clinical trials, DOACs reduced stroke or systemic embolism by 19% overall compared to warfarin, with a 51% reduction in strokes caused by bleeding and a 10% reduction in overall mortality. They also cause less serious bleeding, which is one of the main risks of any blood thinner.
Four DOACs are currently approved, and guidelines recommend their use over warfarin for most people with atrial fibrillation. The exception is patients with mechanical heart valves or significant mitral valve narrowing, who still need warfarin. Importantly, anticoagulation is recommended regardless of how much time a person spends in atrial fibrillation. Even brief episodes carry stroke risk.
When the source is a narrowed carotid artery, treatment may involve a procedure to open the artery or surgery to remove the plaque buildup, alongside cholesterol-lowering medication and antiplatelet drugs. For people with a patent foramen ovale found after a stroke, closure of the hole with a small device threaded through a catheter is sometimes recommended, particularly in younger patients without other obvious stroke risk factors.
Recovery and Outlook
Recovery varies enormously depending on which brain artery was blocked, how much tissue was damaged, and how quickly treatment was received. Some people recover nearly fully within weeks, while others face lasting disability in speech, movement, or cognition. Rehabilitation typically involves physical therapy, occupational therapy, and sometimes speech therapy, often starting within the first days after the stroke. The most rapid improvements usually happen in the first three to six months, though gains can continue for a year or more. The strongest predictor of a second event is having already had one, which is why identifying and treating the underlying source is so critical to long-term outcomes.